We are delighted to announce that the Open PHACTS project will be extendedfor 18 months until the end of February 2016. For the extension two new partners – Laboratorios Almirall S.A. and SciBite Limited – will join the consortium and GlaxoSmithKline (GSK) will act as coordinator.